Moran Wealth Management »

Cymabay Therapeutics shares owned by Moran Wealth Management

Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by Moran Wealth Management from 13F filings

Historical chart of Moran Wealth Management investment in Cymabay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cymabay Therapeutics held by Moran Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cymabay Therapeutics by Moran Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $526k 22k 23.62

More positions owned by Moran Wealth Management

Cadence Design Systems (CDNS)
Parker-Hannifin Corporation (PH)
Novo-nordisk A S Adr (NVO)
Trane Technologies SHS (TT)
Merck & Co (MRK)
Microsoft Corporation (MSFT)
Williams-Sonoma (WSM)
EOG Resources (EOG)
Celanese Corporation (CE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Lockheed Martin Corporation (LMT)
Linde SHS (LIN)
JPMorgan Chase & Co. (JPM)
Bhp Group Sponsored Ads (BHP)
Exxon Mobil Corporation (XOM)

View all positions for Moran Wealth Management

Top funds holding Cymabay Therapeutics

venBio Select Advisor
RA Capital Management
Vanguard Group
Henderson Group
T. Rowe Price Associates
Perceptive Advisors
Franklin Resources
Holocene Advisors
Octagon Capital Advisors
Point72 Asset Management
Fred Alger Management
Cormorant Asset Management
First Turn Management
Deutsche Bank Aktiengesellschaft
Lord, Abbett & Co

View all funds holding Cymabay Therapeutics